Abstract:The first intraocular lenses (IOLs) used for cataract surgery transmitted both ultraviolet (UV) radiation and visible light to the retina. Colorless UV-blocking IOLs were introduced and rapidly adopted in the 1980s. Yellow-tinted blue-blocking (also known as blue-filtering) IOLs were marketed in the early 1990s. Blue-blocking IOLs were intended to simulate age-related crystalline lens yellowing to reduce the cyanopsia that some patients experienced after cataract surgery. When blue-filtering IOLs were introduced in North America, however, blue-blocking chromophores were advocated as a way to protect patients from age-related macular degeneration (AMD) despite the lack of evidence that normal environmental light exposure causes AMD. The "blue light hazard" is a term that describes the experimental finding that acute, abnormally intense light exposures are potentially more phototoxic to the retina when short rather than long wavelengths are used. Thus, in brief exposures to intense light sources such as welding arcs, ultraviolet radiation is more hazardous than blue light, which is more hazardous than longer wavelength green or red light. International commissions have cautioned that the blue light hazard does not apply to normal indoor or outdoor light exposures. Nonetheless, the hazard is used for commercial purposes to suggest misleadingly that ambient environmental light can cause acute retinal phototoxicity and increase the risk of AMD. Very large epidemiological studies show that blue-blocking IOLs do not reduce the risk or progression of AMD. Additionally, blue-filtering IOLs or spectacles cannot decrease glare disability, because they decrease image and glare illuminance in the same proportion. Blue light is essential for older adults' scotopic photoreception needed to reduce the risk of nighttime falling and related injuries. It is also critical for circadian photoreception that is essential for good health, sleep and cognitive performance. Unfortunately, age-related pupillary miosis, retinal rod and ganglion cell photoreceptor degeneration and decreased outdoor activity all reduce the amount of healthful blue light available to older adults. Blue-restricting IOLs further reduce the available blue light at a time when older adults need it most. Patients and ophthalmologists are exposed to hypothesis-based advertisements for blue-filtering optical devices that suppress short wavelength light critical for vision in dim lighting and for good physical and mental health. Spectacle and intraocular lens selections should be based on scientific fact, not conjecture. Ideal IOLs should improve photoreception rather than limit it permanently. Practice efficiency, surgical convenience and physician-manufacturer relationships may eliminate a patient's opportunity to choose between colorless blue-transmitting IOLs and yellow-tinted, blue-restricting IOLs. Cataract surgeons ultimately determine whether their patients have the opportunity to make an informed choice about their future photoreception.

Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro

Protection of blue-light absorbing intraocular lens on retinal pigment epithelium in vitro

Effects of Light Exposure and Use of Intraocular Lens on Retinal Pigment Epithelial Cells in Vitro.

STUDY OF BLUE LIGHT INDUCED DNA DAMAGE OF RETINAL PIGMENT EPITHELIUM(RPE) CELLS AND THE PROTECTION OF VITAMIN C

Light Filtering in A Retinal Pigment Epithelial Cell Culture Model

Clinical Study on Implantation with UV-biocking and Blue-light Filtering Intraocular Lens

Contrast Sensitivity and Glare Sensitivity after Implantation of AcrySof IQ Natural Aspherical Intraocular Lens

Prevention of Sunlight-Induced Cell Damage by Selective Blue-Violet-Light-Filtering Lenses in A2E-Loaded Retinal Pigment Epithelial Cells

In-vitro assessment of a novel intraocular lens made of crosslinked polyisobutylene

Lumière bleue et implants intraoculaires : croyances et réalités

Intraindividual comparison of color contrast sensitivity in patients with clear and blue-light-filtering intraocular lenses

Blue-Light Filtering Monofocal Intraocular Lenses: A Study on Optical Function and Tolerance to Misalignment

Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris

Clinical study of Acrysof IQ aspheric intraocular lenses: Clinical study of aspheric intraocular lenses

A Study on the Safety and Effectivity of Domestic Hydrophobic Acrylic Intraocular Lens

Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and in Vivo Studies

Blue-blocking spectacles lenses for retinal damage protection and circadian rhythm: evaluation parameters

Early Changes in Gene Expression Induced by Blue Light Irradiation of A2E-laden Retinal Pigment Epithelial Cells.

Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study

Long-term Prevalence of Opacification of a Hydrophylic Acrylic Rotationally Asymmetric Refractive Multifocal Intraocular Lens

Physicochemical and surface properties of acrylic intraocular lenses and their clinical significance